cellular therapies Archives - Blogs & Articles

Multiple factors & challenges preventing cell and gene therapies to be widely used- 3rd Annual MarketsandMarkets Cell & Gene Therapy Manufacturing Virtual Conference

July 30, 2021July 30, 2021 MarketsandMarkets Conferences

3rd Annual MarketsandMarkets Cell & Gene Therapy Manufacturing Virtual Conference to be held on 28th – 29th October 2021 will host industry giants like Advanced Cell & Gene Therapy LLC, Cell & Gene Therapy Consulting LLC, panCella, Sigilon Inc, Biotechnology Biopharmaceuticals and many more. The global cell & gene therapy manufacturing services market size is projected to reach USD 13.8 billion by 2026 from USD 7.7 billion in 2021, at a CAGR of 12.4% during the forecast period. Growth in this market is primarily driven by the high incidence of…

Speaker Interview with Fabio D’Agostino for 4th Annual MarketsandMarkets Bioprocessing of Advanced Cellular Therapies & Regenerative Medicine Congress

January 7, 2020 MarketsandMarkets Conferences

London, January 07 – MarketsandMarkets interviewed Fabio D’Agostino,Venture Partner, Claris Ventures regarding 4th Annual MarketsandMarkets Bioprocessing of Advanced Cellular Therapies & Regenerative Medicine Congress taking place on 10-11 March 2020 in London – UK. Q. What is the most trending areas of cellular therapies currently? A. CART and NK cell Q. What are the recent developments and technological advancements? A. CART for solid tumors and NK CAR Q. What are the key take away points from your presentation? A. They are basically summarized in my bullet points. I will…

Speaker Interview with Karin Jennbacken for 4th Annual MarketsandMarkets Bioprocessing of Advanced Cellular Therapies & Regenerative Medicine Congress

December 13, 2019December 16, 2019 MarketsandMarkets Conferences

London, December 13 – MarketsandMarkets interviewed Karin Jennbacken, Team Leader, Heart Failure in vitro team, AstraZeneca regarding 4th Annual MarketsandMarkets Bioprocessing of Advanced Cellular Therapies & Regenerative Medicine Congress taking place on 10-11 March 2020 in London – UK. Dr Jennbacken’s team is responsible for target discovery and early development of therapeutics for treatment of patients with cardiovascular disease. Q. What is the most trending areas of cellular therapies currently? A. Cardiac therapies using pluripotent stem cells is where most of the researches are going on. Q. What are the…

Speaker Interview with Petter Björquist for 4th Annual MarketsandMarkets Bioprocessing of Advanced Cellular Therapies & Regenerative Medicine Congress

December 13, 2019December 13, 2019 MarketsandMarkets Conferences

London, December 13 – MarketsandMarkets interviewed Petter Björquist, CEO, Verigraft regarding 4th Annual MarketsandMarkets Bioprocessing of Advanced Cellular Therapies & Regenerative Medicine Congress taking place on 10-11 March 2020 in London – UK. Petter Björquist is a PhD in Biology/Biochemistry from Gothenburg University, 50 + publications in peer reviewed journals, several book chapters and patents. Q. What is the most trending areas of cellular therapies currently? A. I would say that is 1) CAR T-cell Therapy. This field has exploded, and started a new era in cancer treatment. 2) Genome…

Speaker Interview With Frank Borriello For 2nd Annual MarketsandMarkets Next Gen Immuno-Oncology Congress

July 31, 2019 MarketsandMarkets Conferences

Philadelphia, USA July 31, 2019 – MarketsandMarkets recently interviewed Frank Borriello, CEO, Alloplex Biotherapeutics, regarding the 2nd Annual MarketsandMarkets Next Gen Immuno-Oncology Congress, taking place on September 19 – 20, 2019 at Hilton Garden Inn Philadelphia Center City. Q. What are the recent advances in the immune-oncology and current challenges that need immediate attention? A. While there have been many advances in the field of cellular therapy in oncology, the common element limiting their adoption will be reproducibility of manufacturing, whether autologous or allogeneic, as well as generalizability across multiple tumor types, whether…